E. Gonzalez et al., Global survey of genetic variation in CCR5, RANTES, and MIP-1 alpha: Impact on the epidemiology of the HIV-1 pandemic, P NAS US, 98(9), 2001, pp. 5199-5204
Citations number
32
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Expression of CC chemokine receptor 5 (CCR5), the major coreceptor for HIV-
1 cell entry, and its ligands (e.g., RANTES and MIP-1 alpha) is widely rega
rded as central to the pathogenesis of HIV-1 infection. By surveying nearly
3,000 HIV+ and HIV- individuals from worldwide populations for polymorphis
ms in the genes encoding RANTES, MIP-1 alpha: and CCR5, we show that the ev
olutionary histories of human populations have had a significant impact on
the distribution of variation in these genes, and that this may be responsi
ble, in part, for the heterogeneous nature of the epidemiology of the HIV-1
pandemic, The varied distribution of RANTES haplotypes (AC, GC, and AC) as
sociated with population-specific HIV-I transmission- and disease-modifying
effects is a striking example. Homozygosity for the AC haplotype was assoc
iated with an increased risk of acquiring HIV-1 as well as accelerated dise
ase progression in European Americans, but not in African Americans. Yet. t
he prevalence of the ancestral AC haplotype is high in individuals of Afric
an origin, but substantially lower in non-Africans. In a Japanese cohort, A
G-containing RANTES haplotype pairs were associated with a delay in disease
progression; however, we now show that their contribution to HIV-1 pathoge
nesis and epidemiology in other parts of the world is negligible because th
e AG haplotype is infrequent in non-far East Asians. Thus, the varied distr
ibution of RANTES, MIP-1 alpha, and CCR5 haplotype pairs and their populati
on-specific phenotypic effects on HIV-1 susceptibility and disease progress
ion results in a complex pattern of biological determinants of HIV-1 epidem
iology. These findings have important implications for the design, assessme
nt, and implementation of effective HIV-I intervention and prevention strat
egies.